Mutlu Demiray
Impact in
- Molecular Medicine top 10%
- Curcumin's Biomedical Applications
-
- Cancer Treatment and Pharmacology
- Lung Cancer Research Studies
Papers in
- Oncology 19
- Cancer Treatment and Pharmacology 5
- HER2/EGFR in Cancer Research 4
- Peptidase Inhibition and Analysis 4
- Cancer Immunotherapy and Biomarkers 2
-
- Advanced Breast Cancer Therapies 4
- Co-authors
- Türkkan Evrensel (15 shared papers)Fatemeh Bahadorı (4 shared papers)Osman Manavoğlu (11 shared papers)Ender Kurt (13 shared papers)Özkan Kanat (12 shared papers)Güzin Gönüllü (9 shared papers)İlker Ercan (5 shared papers)Özlem Saraydaroğlu (3 shared papers)
- Journals
- Cancer Investigation (3 papers)Therapeutic Advances in Medical Oncology (3 papers)Journal of Clinical Oncology (2 papers)Medical Oncology (2 papers)JCO Precision Oncology (2 papers)
- Partner nations
- TürkiyeUnited StatesSingapore
In The Last Decade
Mutlu Demiray
37 papers receiving 330 citations
Peers
Comparison fields: 5 of 74
- Molecular Medicine 48
- Oncology 121
- Hematology 32
- Dermatology 18
- Gastroenterology 8
Countries citing papers authored by Mutlu Demiray
This map shows the geographic impact of Mutlu Demiray's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mutlu Demiray with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mutlu Demiray more than expected).
Fields of papers citing papers by Mutlu Demiray
This network shows the impact of papers produced by Mutlu Demiray. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mutlu Demiray. The network helps show where Mutlu Demiray may publish in the future.
Co-authors
The 25 scholars most cited alongside Mutlu Demiray, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 39 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2006 | 58 | |
| 2 | 2017 | 37 | |
| 3 | 2003 | 36 | |
| 4 | 2003 | 25 | |
| 5 | 2021 | 19 | |
| 6 | 2003 | 19 | |
| 7 | Acquired lymphangiectasis after breast conservation treatment for breast cancer: report of a case. | 2004 | 19 |
| 8 | 2016 | 18 | |
| 9 | 2005 | 13 | |
| 10 | 2003 | 12 | |
| 11 | 2017 | 11 | |
| 12 | 2020 | 9 | |
| 13 | 2005 | 8 | |
| 14 | 2004 | 6 | |
| 15 | 2004 | 6 | |
| 16 | 2014 | 6 | |
| 17 | 2005 | 6 | |
| 18 | 2023 | 4 | |
| 19 | 2004 | 4 | |
| 20 | 2002 | 4 |
About Mutlu Demiray
Mutlu Demiray is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Surgery, Molecular Biology and Cancer Research, having authored 39 papers that have together received 348 indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (5 papers), Cancer Genomics and Diagnostics (4 papers), Advanced Breast Cancer Therapies (4 papers), HER2/EGFR in Cancer Research (4 papers), Peptidase Inhibition and Analysis (4 papers), Helicobacter pylori-related gastroenterology studies (3 papers), Curcumin's Biomedical Applications (3 papers) and Cancer Immunotherapy and Biomarkers (2 papers). The work is most often cited by research in Molecular Medicine (48 citations), Oncology (121 citations), Hematology (32 citations), Dermatology (18 citations) and Gastroenterology (8 citations). Mutlu Demiray has collaborated with scholars based in Türkiye, United States and Singapore. Frequent co-authors include Türkkan Evrensel, Fatemeh Bahadorı, Osman Manavoğlu, Ender Kurt, Özkan Kanat, Güzin Gönüllü, İlker Ercan, Özlem Saraydaroğlu, Engı̇n Ulukaya and İbrahim Baran. Their work appears in journals such as Cancer Investigation, Therapeutic Advances in Medical Oncology, Journal of Clinical Oncology, Medical Oncology and JCO Precision Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.